EUVIMEDEUVIMED entdecken
Editorial

HER2-targeted PET for Patients with Breast Cancer: Scintillating Data

Gary A Ulaner iD

Radiology · 01.06.2024 · 311 (3)

DOI: 10.1148/radiol.240814 ↗

Kurz gefasst

Editorial in der Zeitschrift Radiology, erschienen am 01.06.2024. Verfasst von Gary A Ulaner. Beteiligte Einrichtung: From the Department of Molecular Imaging and Therapy, Hoag Family Cancer Institute, 16105 Sand Canyon Ave, Irvine, CA 92618; and Departments of Radio…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Positron-Emission Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesPositron-Emission TomographyHumansFemaleRadiopharmaceuticals

Substanzen

Erb-b2 Receptor Tyrosine KinasesRadiopharmaceuticalsERBB2 protein, human

Autor:innen und Institutionen

  • From the Department of Molecular Imaging and Therapy, Hoag Family Cancer Institute, 16105 Sand Canyon Ave, Irvine, CA 92618; and Departments of Radiology and Translational Genomics, University of Southern California, Lo…

ORCID-Profile: Gary A Ulaner

Zitieren

APA

Ulaner, G. A. (2024). HER2-targeted PET for Patients with Breast Cancer: Scintillating Data. Radiology, 311(3). https://doi.org/10.1148/radiol.240814

Vancouver

Ulaner GA. HER2-targeted PET for Patients with Breast Cancer: Scintillating Data. Radiology. 2024;311(3). doi:10.1148/radiol.240814

BibTeX
@article{Ulaner2024,
  author = {Ulaner, Gary A},
  title = {HER2-targeted PET for Patients with Breast Cancer: Scintillating Data},
  journal = {Radiology},
  year = {2024},
  volume = {311},
  number = {3},
  doi = {10.1148/radiol.240814}
}
Kostenlos starten →